Publication | Closed Access

Possibility of the reversal of multidrug resistance and the avoidance of side effects by liposomes modified with MRK-16, a monoclonal antibody to P-glycoprotein

Lipid PreparationProteinlipid InteractionMedicineImmunologySide EffectsMultidrug ResistanceImmunotherapyPharmacologyMonoclonal AntibodyDrug DiscoveryDrug Resistance